Elez E - Search Results

1

Phase I prognostic online (PIPO): A web tool to improve patient selection for oncology early phase clinical trials.

Matos I, Villacampa G, Hierro C, Martin-Liberal J, Berché R, Pedrola A, Braña I, Azaro A, Vieito M, Saavedra O, Gardeazabal I, Hernando-Calvo A, Alonso G, Galvao V, Ochoa de Olza M, Ros J, Viaplana C, Muñoz-Couselo E, Elez E, Rodon J, Saura C, Macarulla T, Oaknin A, Carles J, Felip E, Tabernero J, Dienstmann R, Garralda E. Matos I, et al. Among authors: elez e. Eur J Cancer. 2021 Sep;155:168-178. doi: 10.1016/j.ejca.2021.05.040. Epub 2021 Aug 9. Eur J Cancer. 2021. PMID: 34385069 Free article. Clinical Trial.

2

Oxaliplatin-based chemotherapy in the management of colorectal cancer.

Capdevila J, Elez E, Peralta S, Macarulla T, Ramos FJ, Tabernero J. Capdevila J, et al. Among authors: elez e. Expert Rev Anticancer Ther. 2008 Aug;8(8):1223-36. doi: 10.1586/14737140.8.8.1223. Expert Rev Anticancer Ther. 2008. PMID: 18699761 Review.

3

Handling side-effects of targeted therapies: safety of targeted therapies in solid tumours.

Elez E, Macarulla T, Tabernero J. Elez E, et al. Ann Oncol. 2008 Sep;19 Suppl 7:vii146-52. doi: 10.1093/annonc/mdn476. Ann Oncol. 2008. PMID: 18790937 Free article. No abstract available.

4

Update on novel strategies to optimize cetuximab therapy in patients with metastatic colorectal cancer.

Macarulla T, Ramos FJ, Elez E, Capdevila J, Peralta S, Tabernero J. Macarulla T, et al. Among authors: elez e. Clin Colorectal Cancer. 2008 Sep;7(5):300-8. doi: 10.3816/CCC.2008.n.039. Clin Colorectal Cancer. 2008. PMID: 18794061 Review.

5

The role of salvage treatment in advanced colorectal cancer.

Capdevila J, Ramos FJ, Macarulla T, Elez E, Tabernero J. Capdevila J, et al. Among authors: elez e. Crit Rev Oncol Hematol. 2009 Jul;71(1):53-61. doi: 10.1016/j.critrevonc.2008.09.006. Epub 2008 Nov 1. Crit Rev Oncol Hematol. 2009. PMID: 18977669 Review.

6

Understanding the predictive role of K-ras for epidermal growth factor receptor-targeted therapies in colorectal cancer.

Ramos FJ, Macarulla T, Capdevila J, Elez E, Tabernero J. Ramos FJ, et al. Among authors: elez e. Clin Colorectal Cancer. 2008 Dec;7 Suppl 2:S52-7. doi: 10.3816/CCC.2008.s.008. Clin Colorectal Cancer. 2008. PMID: 19064407 Review.

7

Anti-epidermal growth factor receptor monoclonal antibodies in cancer treatment.

Capdevila J, Elez E, Macarulla T, Ramos FJ, Ruiz-Echarri M, Tabernero J. Capdevila J, et al. Among authors: elez e. Cancer Treat Rev. 2009 Jun;35(4):354-63. doi: 10.1016/j.ctrv.2009.02.001. Epub 2009 Mar 6. Cancer Treat Rev. 2009. PMID: 19269105 Review.

8

Development of new drug strategies in infrequent digestive tumors: esophageal, biliary tract, and anal cancers.

Capdevila J, Ramos FJ, Macarulla T, Elez E, Ruiz-Echarri M, Perez-Garcia J, Tabernero J. Capdevila J, et al. Among authors: elez e. Curr Opin Oncol. 2009 Jul;21(4):374-80. doi: 10.1097/CCO.0b013e32832c9464. Curr Opin Oncol. 2009. PMID: 19412097 Review.

9

Panitumumab - an effective long-term treatment for patients with metastatic colorectal cancer and wild-type KRAS status.

Elez E, Alsina M, Tabernero J. Elez E, et al. Cancer Treat Rev. 2010 Feb;36 Suppl 1:S15-6. doi: 10.1016/S0305-7372(10)70003-7. Cancer Treat Rev. 2010. PMID: 20189055 Review. No abstract available.

10

New trends in epidermal growth factor receptor-directed monoclonal antibodies.

Markman B, Capdevila J, Elez E, Tabernero J. Markman B, et al. Among authors: elez e. Immunotherapy. 2009 Nov;1(6):965-82. doi: 10.2217/imt.09.66. Immunotherapy. 2009. PMID: 20635913 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

153 results

Search Page